Cargando…
A harm reduction model to assess the impact of new treatments for pain over standard of care among patients with osteoarthritis
BACKGROUND: Osteoarthritis (OA) affects millions of adults in the United States and can result in substantial pain, functional impairment, and significant clinical and economic burden. To manage chronic pain associated with OA, treatment guidelines recommend a variety of pharmacologic treatments, in...
Autores principales: | Silverman, Stuart, Schepman, Patricia, Rice, J Bradford, Robinson, Rebecca L, White, Alan G, Fernan, Catherine, Beck, Craig G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391000/ https://www.ncbi.nlm.nih.gov/pubmed/34818088 http://dx.doi.org/10.18553/jmcp.2021.27.12.1652 |
Ejemplares similares
-
Clinical and economic burden of prescribing tramadol and other opioids for patients with osteoarthritis in a commercially insured population in the United States
por: Silverman, Stuart, et al.
Publicado: (2022) -
Risk Factors Associated with Falls and Fractures Following Prescription of Opioids Among Privately Insured Patients with Osteoarthritis
por: Silverman, Stuart, et al.
Publicado: (2022) -
Moderate to Severe Osteoarthritis Pain and Its Impact on Patients in the United States: A National Survey
por: Schepman, Patricia, et al.
Publicado: (2021) -
A Retrospective Claims-Based Study Evaluating Clinical and Economic Burden Among Patients With Moderate to Severe Osteoarthritis Pain in the United States
por: Schepman, Patricia B., et al.
Publicado: (2022) -
Concern about addiction is associated with lower quality of life in patients with osteoarthritis: an exploratory, real-world data analysis
por: Garrison, Louis P., et al.
Publicado: (2021)